Condition

ALK-positive Non-small Cell Lung Cancer clinical trials and research

• 6Clinical trials
• 6Countries

Newest ALK-positive Non-small Cell Lung Cancer clinical trials

All recruiting trials (6)

• NXP900 with Lorlatinib in ALK-positive NSCLC

  This study tests whether adding NXP900 to lorlatinib helps people with ALK-positive non-small cell lung cancer who have already received prior therapy.

  Recruiting Phase 1 Nuvectis Pharma, Inc. · Fairfax, Virginia · NCT07784959

• AQUA07 in ALK-positive NSCLC (phase 1)

  This early-stage trial tests AQUA07 alone and with lorlatinib to see if it is safe and tolerable for adults with ALK-positive non-small cell lung cancer who have tried other ALK inhibitors.

  Recruiting at 7 sites Phase 1 Chugai Pharmaceutical · Houston, Texas and 6 other locations · NCT07617337

• TRI-611 for ALK-positive non-small cell lung cancer (Phase 1/2)

  This trial will test TRI-611 to see if it is safe and can shrink tumors in adults with ALK-positive non-small cell lung cancer, including people with different past ALK treatments.

  Recruiting at 20 sites Phase 1/2 TRIANA Biomedicines, Inc. · San Francisco, California and 19 other locations · NCT07491497

• Observational study of lorlatinib for advanced ALK-positive lung cancer patients

  This study looks at how well lorlatinib works and how safe it is for people with advanced ALK-positive lung cancer who are receiving treatment.

  Recruiting Sichuan Cancer Hospital and Research Institute · Chengdu, Sichuan · NCT06361589

• First-line treatment with lorlatinib for advanced ALK+ lung cancer in China

  This study is testing if lorlatinib can be an effective first treatment for people in China with advanced ALK-positive lung cancer.

  Recruiting Phase 2 Guangdong Association of Clinical Trials · Guangzhou, Guangdong · NCT06092086

• Supportive care model for patients with advanced lung cancer

  This study is testing a new supportive care program for people with advanced lung cancer to see if it helps them feel less stressed and more confident about managing their condition compared to standard care.

  Recruiting Massachusetts General Hospital · Boston, Massachusetts · NCT04900935

Related topics

Quick answers

How many ALK-positive Non-small Cell Lung Cancer clinical trials are recruiting right now?

6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 6 countries. The most sites are in United States (4 trials), China (2 trials), Australia (1 trial), France (1 trial), United Kingdom (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 2, Phase 2: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →